EXVASTAT
Exvastat is an innovative, preclinical-stage pharmaceutical company founded in 2016. The company is developing a treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The new treatment has the potential to significantly reduce the high mortality and incapacitating morbidities caused by ARDS, as well as the costs of caring for these critically ill patients to health service providers.
EXVASTAT
Industry:
Biotechnology Health Care Life Science Medical Pharmaceutical
Founded:
2016-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.exvastat.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3.9 M USD
Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail Google Apps For Business Cloudflare JS CDN JS Pexels Twitter CDN WordPress 5.5
Current Advisors List
Current Employees Featured
Founder
Investors List
Innovative Medicines Initiative
Innovative Medicines Initiative investment in Grant - Exvastat
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Seed Round - Exvastat
Official Site Inspections
http://www.exvastat.com
- Host name: olympus-lon.cloudhosting.uk
- IP address: 185.199.220.69
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
